Health Care › Biological Products (No Diagnostic Substances)

Brickell Biotech (BBI) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with BBI stock chart to see long term trends.

BBI stock compared to

BBI Income Statement

Revenue, Net:

Revenue Per Share:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Net Income:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

BBI Cash Flow

Operating Activities Net Income:

Net Cash from Operations:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

BBI Balance Sheet

Cash and Cash Equivalents:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Total Short-Term Liabilities:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Sabby Management, LLC

721,887 sh

721,887 sh
NEW

$652

Vanguard Group Inc

634,078 sh

281,200 sh
80%

$573

$220

Renaissance Technologies LLC

618,150 sh

133,156 sh
27%

$558

$73

Blackrock Inc.

44,431 sh

$40

Morgan Stanley

2,086 sh

-15 sh
-1%

Bank Of America Corp /De/

305 sh

-1,359 sh
-82%

-$2

Goldman Sachs Group Inc

0 sh

-74,277 sh
-100%

-$74

Proequities, Inc.

0 sh

Data imported from Brickell Biotech, Inc. SEC filings. Check original filings before making any investment decision.